Moreover, further elucidation is needed in several areas, including clarifying the mechanism by which gastric cancer cells secrete ILF2 and investigating the impact of inhibiting the functional activity of extracellular ILF2 with neutralizing antibodies or small molecules (if available) on the biological behavior of gastric cancer, which will be crucial for revealing the therapeutic potential of ILF2. The gene discussed is ILF2; the disease is gastric cancer.